Liquid proliposomes of nimodipine drug delivery system: Preparation, characterization, and pharmacokinetics

AAPS PharmSciTech

Volumn 14, Issue 1, 2013, Pages 332-338

  Sun, Chuandi ^a,b   Wang, Ji ^a   Liu, Jianping ^a   Qiu, Lu ^a   Zhang, Wenli ^a   Zhang, Lei ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Synasia Co Ltd   (China)

Author keywords

liquid proliposomes; nimodipine; pharmacokinetics; soft capsules; stability

Indexed keywords

HYDROCHLORIC ACID; LIPOSOME; LIQUID PROLIPOSOME; NIMODIPINE; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; EXPERIMENTAL RABBIT; IN VIVO STUDY; MALE; MOLECULAR STABILITY; NONHUMAN; PARTICLE SIZE; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANIMALS; CALCIUM CHANNEL BLOCKERS; LIPOSOMES; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NIMODIPINE; RABBITS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 84878594413     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-013-9924-6     Document Type: Article

References (33)

1. Gelmers HJ. Calcium-channel blockers in the treatment of migraine. Am J Cardiol. 1985;55:139B-43B.
2. Langley MS, Sorkin EM. Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. Drugs. 1989;37:669-99.
3. He Z, Zhong D, Chen X, Liu X, Tang X, Zhao L. Development of a dissolution medium for nimodipine soft capsules based on bioavailability evaluation. Eur J Pharm Sci. 2004;21(4):487-91.
4. Grunenberg A, Keil B, Henck JO. Polymorphism in binary mixture, as exemplified by nimodipine. Int J Pharm. 1995;118(1):11-21.
5. Berson JA, Brown E. Studies in the synthesis of cortisone. J Am Chem Soc. 1955;77(2):447-50.
6. Mi Z, Burke TG. Marked interspecies variations concerning the interactions of camptothecin with serum albumins, a frequency-domain fluorescence spectroscopic study. Biochemistry. 1994;33(42):12540-5.
7. Gabizon A, Dagan A, Goren D, Barenholz Y, Fuks Z. Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice. Cancer Res. 1982;42:4734-9.
8. Rajesh K, Gupta RB, Betageri GV. Formulation, characterization, and in vitro release of glyburide from proliposomal beads. Drug Deliv. 2001;8:25-7.
9. Payne NI, Timmis P, Ambrose CV, Warel MD. Proliposomes: a novel solution to an old problem. J Pharm Sci. 1986;75:325-9.
10. Junping W, Maitani Y, Takayama K, Nagai T. In vivo evaluation of doxorubicin carried with long circulating and remote loading proliposome. Int J Pharm. 2000;203:61-9.
11. Dayan N, Touitou E. Carriers for skin delivery of trihexyphe-nidyl HCl: ethosomes vs. liposomes. Biomaterials. 2000;21:1879-85.
12. Gao XL, Ji XM. Determining the trap efficiency of liposome using Sephadex column chromatography. J China Pharm. 2003;38(7):515-7.
13. Matsuzaki K, Murase O, Sugishita K, et al. Optical characterization of liposomes by right angle light scattering and turbidity measurement. Biochim Biophys Acta. 2000;1467(1):219.
14. Brocks DR, Betageri GV. Enhanced oral absorption of halofantrine enantiomers after liposomal encapsulation. J Pharm Pharmacol. 2002;54:1049-53.
15. Chansiri G, Lyons RT, Patel MV, Hem SL. Effect of surface charge on the stability of oil/water emulsions during steam sterilization. J Pharm Sci. 1999;88(4):454-8.
16. Lyklema J, Fleer GJ. Zeta electrical contributions to the effect of macro-molecules on colloid stability. Colloid Surf. 1987;25:357-68.
17. Wiacek A, Chibowski E. Zeta potential, effective diameter and multimodal size distribution in oil/water emulsion. Colloid Surf. 1999;159:253-61.
18. Mehnert W, Mader K. Solid lipid nanoparticles. Production characterization and applications. Adv Drug Deliv Rev. 2001;47:165-96.
19. Liu J, Gong T, Wang CG, Zhong ZR, Zhang ZR. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Int J Pharm. 2007;340:153-62.
20. Kossena GA, Boyd BJ, Porter CJ, Channan WN. Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs. J Pharm Sci. 2003;92:634-48.
21. Fahr A, van Hoogevest P, May S, Bergstrand N, Mathew L, Leigh S. Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery. Eur J Pharm Sci. 2005;26:251-65.
22. Chen Y, Lu Y, Chen J, Lai J, Sun J, Hu F, et al. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int J Pharm. 2009;376:153-60.
23. Hildebrand A, Beyer K, Neubert R, Garidel P, Blume A. Temperature dependence of the interaction of cholate and deoxycholate with fluid model membranes and their solubilization into mixed micelles. Colloid Surf B Biointerfaces. 2003;32:335-51.
24. Porter CJ, Trevaskis NL, Charman WN. Lipid and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007;6:231-48.
25. Digenis GA, Gold TB, Shah VP. Cross linking of gelatin within capsules and its relevance to their in vitro-in vivo performance. J Pharm Sci. 1994;83(7):915-21.
26. Iwanaga K, Ono S, Narioka K, Morimoto K, Kakemi M, Yamashita S, et al. Oral delivery of insulin by using surface coating liposomes. Improvement of stability of insulin in GI tract. Int J Pharm. 1997;157:73-80.
27. Xu H, He L, Nie S, Guan J, Zhang X, Yang X, et al. Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits. J Contr Release. 2009;140:61-8.
28. Gupta S, Pal Singh R, Lokwani P, Yadav S, Gupta SK. Vesicular system as targeted drug delivery system: an overview. Int J Pharm Tech. 2011;3:987-1021.
29. Hussain N, Jaitley V, Florence AT. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev. 2001;50:107-42.
30. Stuart DD, Allen TM. A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability. Biochim Biophys Acta. 2000;146:3219-29.
31. Yuan H, Chen J, Du YZ, Hu FQ, Zeng S, Zhao HL. Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloid Surf B. 2007;58:157-64.
32. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58:173-82.
33. Lim SJ, Lee MK, Kim CK. Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders. J Contr Release. 2004;100:53-61.